
Nodules and granulomas are one of the most common concerns after aesthetic injections, especially dermal fillers. While they can be worrying, they are usually manageable when identified early and treated correctly. Understanding what they are, when they appear, and how to manage them is essential for anyone considering filler treatments.
What Are Nodules and Granulomas?
A nodule is simply a small lump that appears after treatment. It is a clinical description, not a diagnosis. Nodules can result from excess filler or product in the wrong plane, uneven filler distribution, infection or biofilm formation, an allergic or immune reaction, or a true foreign-body granuloma.
A granuloma is a specific type of chronic inflammation where the body walls off something it sees as foreign, such as filler particles. Under the microscope, granulomas show clusters of immune cells and multinucleated giant cells. While biopsy is required for a definitive diagnosis, in practice clinicians often rely on timing and appearance to guide treatment.
How Common Are They?
True foreign-body granulomas are rare, occurring in roughly one in 100 to one in 5000 filler patients, depending on the product. Simple nodules are more common; one large study reported them in about 2.6% of treatments, with risk strongly influenced by the specific filler used.
In lip augmentation, nodules that appear months or years after treatment are uncommon but well documented. One systematic review found that the average onset was around 35 months after the first injection, and most biopsied lesions were granulomas.
When Do They Appear?
Timing can help distinguish nodules from granulomas. Early nodules appear within hours to four weeks. These are often due to technical or product-related issues, such as overfilling, superficial placement, or gel clumping. They can also reflect early infection or hypersensitivity reactions.
Delayed nodules or granulomas appear one month to many years after injection. They are usually linked with collagen-stimulating fillers like PMMA, PLLA, CaHA, PCL, or dextran. Average onset is around 20 months, though cases have been reported as early as one week and as late as 15 years. Lip fillers often show mean onset around three years. Granulomas typically appear at all injection sites at once after a silent period.
How Do They Present?
Simple, non-inflammatory nodules appear as small, firm, or rubbery lumps. They are usually painless and skin-colored, sometimes only palpable, and generally confined to one site corresponding to the filler bolus.
Inflammatory nodules or granulomas are more likely to be red, swollen, and sometimes warm or tender. They may appear in multiple areas, grow larger than the expected filler volume, and fluctuate in size, sometimes triggered by infections, vaccines, or dental work. Infection or biofilm-related nodules may be painful, red, and occasionally form abscesses or drainage.
Which Products Carry Higher Risk?
All fillers can theoretically provoke granulomas, but risk differs by product. Collagen-stimulating and permanent fillers such as PMMA, PLLA, CaHA, PCL, dextran, polyvinyl alcohol, and silicone are repeatedly linked with foreign-body granulomas and long latency periods. A 2024 systematic review found nodules in about 83% of reported granuloma cases, most often with PMMA and PLLA, followed by CaHA and PCL.
Hyaluronic acid (HA) fillers are generally safer and reversible, but delayed-onset nodules and inflammatory reactions can still occur, particularly with newer highly cross-linked or low–molecular-weight formulations.
Who Is at Higher Risk?
Certain patient factors increase the likelihood of complications. Immunomodulated or immunosuppressed patients are more prone to nodules and infections. Underlying or latent autoimmune or granulomatous diseases may trigger delayed granulomatous reactions. A large cumulative filler load, use of multiple products, or fillers that persist in tissue for long periods also increases risk.
Some treatment areas are more prone to complications, particularly the perioral/lip area, nasolabial folds, and cheeks.
How Are Nodules and Granulomas Managed?
Management should match the underlying cause. Over-treating a simple nodule or using steroids on an infection can worsen outcomes.
Early, non-inflamed HA nodules caused by product misplacement often respond to gentle massage and observation. Persistent or aesthetically concerning nodules can be dissolved using hyaluronidase.
Early painful, red, or hot nodules may indicate infection or biofilm. Culture should be performed if possible, followed by systemic antibiotics and drainage if abscesses are present. Steroids should be delayed until infection is controlled.
Delayed, firm nodules, likely foreign-body granulomas, are typically treated with intralesional corticosteroids such as triamcinolone. These injections may be repeated every four weeks and can be combined with 5-fluorouracil to reduce the risk of skin atrophy. For HA-based granulomas, hyaluronidase can also be used to remove the antigenic stimulus. Surgery is considered a last resort, as granulomas often have finger-like projections that make excision challenging, though early surgery can sometimes shorten treatment duration if conservative management fails.
General principles include taking a careful history, considering biopsy for delayed or atypical nodules, and using ultrasound where available to map filler and guide treatment.
Prevention: What Really Helps?
Prevention starts before the syringe is picked up. A thorough pre-procedure assessment should screen for autoimmune disease, chronic infections, immunomodulating drugs, and recent infections, vaccinations, or dental work. Previous fillers should be discussed, and layering new products over permanent or unknown materials should be avoided.
Product choice matters. Reversible HA fillers are preferred, and understanding each product’s cross-linking, longevity, and ideal injection depth is essential. Large boluses of collagen-stimulating fillers should be avoided in high-movement or high-risk areas.
Meticulous technique and sterility are key. Proper skin preparation, aseptic handling, correct plane and volume, and minimizing repeated needle passes help reduce biofilm formation and infection risk.
Comprehensive reviews consistently highlight that nodules and granulomas are usually preventable with careful patient selection, appropriate product choice, and careful technique. When recognized early and managed systematically, outcomes are generally excellent.
If you want fitness tips, evidence-based workouts, and practical guidance for both your health and aesthetics, follow me on Instagram @sarahcurranfitpro.
Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any questions about aesthetic procedures or medical conditions.








